Keywords: gpc, biotech, submits, clinical, section, satraplatin, nda

GPC biotech submits clinical section of satraplatin NDA

Article | 17 July 2006

Print This

Germany's GPC Biotech AG has submitted the clinical section of an ongoing New Drug Application to the US Food and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in